A client asks the nurse what ventilation is. What is the most appropriate response by the nurse?

A) Montelukast:
Montelukast is a leukotriene receptor antagonist used for the long-term control and prevention of asthma symptoms, but it is not typically used as a rescue medication to abort an ongoing asthma attack. Its onset of action is slower compared to short-acting beta agonists like albuterol.

B) Fluticasone:
Fluticasone is an inhaled corticosteroid medication used for the long-term control and management of asthma symptoms by reducing airway inflammation and preventing asthma exacerbations. It is not used as a rescue medication to abort an ongoing asthma attack but rather as a controller medication to prevent symptoms when used regularly over time.

C) Cromolyn:
Cromolyn is a mast cell stabilizer medication that is used for the prevention of asthma symptoms and exercise-induced bronchospasm. It is not typically used as a rescue medication to abort an ongoing asthma attack but rather as a controller medication to prevent symptoms when used regularly over time.

D) Albuterol.
Albuterol is a short-acting beta agonist bronchodilator commonly used as a rescue or reliever medication for acute asthma symptoms or to abort an ongoing asthma attack. It works quickly to relax the smooth muscles of the airways, leading to rapid bronchodilation and relief of symptoms such as wheezing, shortness of breath, and chest tightness. Albuterol is considered a first-line medication for relieving acute asthma symptoms and should be used as directed by a healthcare provider during an asthma exacerbation.

A) This is normal.
Guaifenesin is an expectorant medication commonly used to help loosen and thin mucus in the airways, making it easier to cough up. Coughing up phlegm after taking guaifenesin is an expected response and indicates that the medication is working as intended. Guaifenesin helps to clear the airways of excess mucus, which can be particularly beneficial for individuals with respiratory conditions such as bronchitis or chest congestion.

B) This requires further investigation.
Coughing up phlegm after taking guaifenesin is a common and expected response and does not typically indicate a need for further investigation unless there are other concerning symptoms present. It is important for the nurse to provide reassurance and education about the expected effects of the medication.

C) This is indicative of an allergic reaction.
Coughing up phlegm after taking guaifenesin is not indicative of an allergic reaction. Allergic reactions to guaifenesin are rare but may include symptoms such as rash, itching, swelling, dizziness, or difficulty breathing. If the client were experiencing these symptoms, it would be important to assess further for a possible allergic reaction and intervene accordingly.

D) This means there is probably more pathology present.
Coughing up phlegm after taking guaifenesin does not necessarily indicate the presence of more pathology. It simply indicates that the medication is helping to loosen and mobilize mucus in the airways, which is a normal response to expectorant therapy. If the client has concerns about their symptoms, further assessment by a healthcare provider may be warranted, but coughing up phlegm alone is not necessarily indicative of worsening pathology.